India  

Pfizer

Multinational pharmaceutical corporation

Pfizer    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Pfizer: Multinational pharmaceutical corporation
Pfizer Inc. is an American multinational pharmaceutical corporation. Pfizer is one of the world's largest pharmaceutical companies, and was ranked 64th on the 2020 Fortune 500 list of the largest U.S. corporations by total revenue, at $51.75 billion.

0
shares
ShareTweetSavePostSend
 
Minister: Government following ‘clear advice’ over vaccines [Video]

Minister: Government following ‘clear advice’ over vaccines

Communities Secretary Robert Jenrick has insisted that the government is "following the very clear advice" from medical leaders when questioned on the decision administer the second Pfizer-BioNTech jab..

Credit: ODN     Duration: 00:42Published
BMA calls for gap between Covid vaccination to be halved [Video]

BMA calls for gap between Covid vaccination to be halved

Dr Chaand Nagpaul, chair of the British Medical Association has called for the maximum time period between people receiving their first and second Pfizer-BioNTech Covid-19 vaccinations to be cut from..

Credit: ODN     Duration: 00:59Published

Pfizer to join WHO co-led vaccine scheme: sources [Video]

Pfizer to join WHO co-led vaccine scheme: sources

Pfizer and BioNTech have agreed to supply their COVID-19 vaccine to the World Health Organization co-led COVAX vaccine access scheme, two sources familiar with the deal said, the latest in a series of..

Credit: Reuters Studio     Duration: 01:40Published
COVID vaccinations: Second shot delays not recommended by global health chiefs [Video]

COVID vaccinations: Second shot delays not recommended by global health chiefs

International organisations are calling any breaks between the Pfizer/BioNTech vaccine doses not to be extended beyond 21 days. Both Pfizer and Moderna also do not support the delay strategy touted by..

Credit: Euronews English     Duration: 02:38Published
Pfizer vaccine appears effective against UK variant [Video]

Pfizer vaccine appears effective against UK variant

The COVID-19 vaccine developed by Pfizer and BioNTech is likely to protect against a more infectious variant of the virus, which was discovered in Britain and has spread around the world, according to..

Credit: Reuters Studio     Duration: 01:15Published
Some nations unable to make most of Pfizer shots [Video]

Some nations unable to make most of Pfizer shots

Switzerland, France and Germany say they're struggling to get the recommended six shots out of each vial of vaccine made by Pfizer and BioNTech, potentially slowing the rollout of inoculations. Julian..

Credit: Reuters Studio     Duration: 01:15Published
Norway: No link established after post-COVID-19 vaccination deaths, says health authority [Video]

Norway: No link established after post-COVID-19 vaccination deaths, says health authority

Norway has stressed that there was no established link between the Pfizer/BioNTech COVID-19 vaccine and the deaths of elderly people who had been vaccinated.

Credit: euronews (in English)     Duration: 02:39Published
CDC warns new Covid-19 variants could accelerate spread in US [Video]

CDC warns new Covid-19 variants could accelerate spread in US

CNN’s Erica Hill reports on confusion around the amount of second doses of the coronavirus vaccine from Pfizer as the CDC warns the new Covid-19 variants could accelerate the spread of Covid-19 in..

Credit: Bleacher Report AOL     Duration: 02:15Published
Pfizer Vaccine Shortage [Video]

Pfizer Vaccine Shortage

Credit: FRANCE 24 English     Duration: 05:54Published
Vaccine manufacturing is lumpy, UK says [Video]

Vaccine manufacturing is lumpy, UK says

Britain's vaccine rollout is limited by a "lumpy" manufacturing process with production changes by Pfizer and a delay by AstraZeneca that could lead to brief supply disruption, Vaccine Deployment..

Credit: Reuters Studio     Duration: 01:24Published
Easing of lockdown restrictions not before March, says Zahawi [Video]

Easing of lockdown restrictions not before March, says Zahawi

Vaccines minister Nadhim Zahawi has suggested that a gradual easing oflockdown restrictions will not begin before early March. He told BBCBreakfast: “If we take the mid-February target, two weeks..

Credit: PA - Press Association STUDIO     Duration: 00:53Published
Phase 3 trial of Pfizer, Moderna underway, benefits are overwhelming compared to risk: VK Paul [Video]

Phase 3 trial of Pfizer, Moderna underway, benefits are overwhelming compared to risk: VK Paul

NITI Aayog Member (Health) Dr VK Paul said that phase 3 trial of Pfizer, Moderna is still going on but the benefits are overwhelming compared to risk. "World has decided to move forward, take benefit..

Credit: ANI     Duration: 01:14Published
COVID vaccines: Six EU countries hit out at 'unacceptable' delays to deliveries of Pfizer jab [Video]

COVID vaccines: Six EU countries hit out at 'unacceptable' delays to deliveries of Pfizer jab

"Fewer doses will be available for European countries at the end of January and the beginning of February," said Pfizer.

Credit: Euronews English     Duration: 03:40Published
Pfizer Study Suggests COVID Vaccine Works Against Different Strains [Video]

Pfizer Study Suggests COVID Vaccine Works Against Different Strains

Pfizer and researchers from the University of Texas Medical Branch in Galveston teamed up for the study.

Credit: Cover Video STUDIO     Duration: 01:06Published
Coronavirus pandemic: EU doubles BioNTech/Pfizer vaccine order to 600 million doses [Video]

Coronavirus pandemic: EU doubles BioNTech/Pfizer vaccine order to 600 million doses

Credit: FRANCE 24 English     Duration: 01:45Published
5 cosas: UE compra más vacunas y SpaceX realiza primer lanzamiento de 2021 [Video]

5 cosas: UE compra más vacunas y SpaceX realiza primer lanzamiento de 2021

En el Reino Unido, el gobierno pedirá pruebas obligatorias de covid-19 para todas las personas que lleguen desde el exterior. La Unión Europea comprará hasta 300 millones de vacunas adicionales de..

Credit: Bleacher Report AOL     Duration: 02:19Published
UK approves its third COVID-19 vaccine as regulator gives green light to Moderna jab [Video]

UK approves its third COVID-19 vaccine as regulator gives green light to Moderna jab

Moderna's shot is easier to handle than the Pfizer vaccine because it doesn't need to be stored at ultra-frozen temperatures.

Credit: Euronews English     Duration: 01:14Published
EU doubles COVID vaccine deal with Pfizer [Video]

EU doubles COVID vaccine deal with Pfizer

The European Union reached a deal with Pfizer and BioNTech for 300 million additional doses of their COVID-19 vaccine, the head of the European Commission said on Friday, in a move that would give the..

Credit: Reuters Studio     Duration: 01:17Published
EU double order of Pfizer jab enough to vaccinate 380 million Europeans [Video]

EU double order of Pfizer jab enough to vaccinate 380 million Europeans

European Commission president Ursula von der Leyen has announced that the EUhas reached a deal to order 300 million extra doses of the BioNTech-PfizerCovid-19 vaccine, doubling the amount that will be..

Credit: PA - Press Association STUDIO     Duration: 01:21Published
Pfizer Covid-19 vaccine ‘works against rapid spread mutant strains’ [Video]

Pfizer Covid-19 vaccine ‘works against rapid spread mutant strains’

The Covid-19 vaccine from Pfizer and BioNTech protects against two new mutantvariants that are causing rapid spread across the UK, new research suggests.The pharmaceutical giant and researchers from..

Credit: PA - Press Association STUDIO     Duration: 00:30Published

You Might Like


Halve the gap between vaccine doses, senior doctors urge

halve the gap between vaccine doses, senior doctors urge
Senior doctors have called on England's chief medical officer to halve the gap between the first and second doses of the Pfizer coronavirus vaccine.
Sky News - Published

UK to look 'very carefully' at vaccine dosing after concerns over level of protection

The UK will need to look "very carefully" at the protection provided by the Pfizer/BioNTech vaccine, the government's chief scientific adviser has told Sky News, amid concerns its effectiveness is..
Sky News - Published

'Real-world' analysis of COVID vaccine raises questions about UK strategy

'real-world' analysis of covid vaccine raises questions about uk strategy
The first real-world analysis of the Pfizer coronavirus vaccine suggests it is matching its performance in clinical trials, but raises serious questions about the UK's decision to delay the second..
Sky News - Published

Pfizer to cut COVID vaccine deliveries as it upgrades production facility

pfizer to cut covid vaccine deliveries as it upgrades production facility
Pfizer has confirmed it is planning to temporarily slow deliveries of its coronavirus vaccine to Europe while it focuses on upscaling its manufacturing facilities.
Sky News - Published

Pfizer delay will not stop UK from vaccinating top priority groups by mid-February, government says

The government says that it is still planning to vaccinate the top four priority groups by mid-February, despite expected production delays for the Pfizer vaccine.
Sky News - Published

India wants Pfizer to do local study for approval: Official


IndiaTimes - Published

Vaccine boost for EU with medics now allowed to draw six doses from single Pfizer vial

vaccine boost for eu with medics now allowed to draw six doses from single pfizer vial
The European Union's drug agency is now allowing doctors to draw up to six doses from each vial of the Pfizer/BioNTech vaccine.
Sky News - Published

Concern over COVID variant but Pfizer research suggests jab still effective

concern over covid variant but pfizer research suggests jab still effective
Concern has been raised about how effective coronavirus vaccines are against the new South African variant, but new research from Pfizer suggests its jab may still work.
Sky News - Published

Covaxin can offer protection against mutated coronavirus: Bharat Biotech

Vaccine makers like Pfizer and AstraZeneca have also said that their vaccines against Covid-19 should work against the new strain.
DNA - Published

AOC Marvelously Explains What COVID Vaccine Does, Gets Shot Herself

Rep. Alexandria Ocasio-Cortez just gave an awesome break-down of what's in the COVID vaccine, what it'll do and how it works ... this after getting the shot herself. The New York Congresswoman hopped..
TMZ.com - Published

COVID vaccine distribution requires funding of Rs 80,000 crore, says Serum Institute of India

Serum Institute-Oxford's Covishield, Bharat Biotech's Covaxin and Pfizer vaccine are in the fray for emergency use authorization.
DNA - Published

Pfizer Says Millions of COVID Vaccine Doses Are Sitting in a Warehouse

Pfizer says it's sitting on liquid gold -- a warehouse packed with the COVID-19 vaccine -- but it can't get word from the government on where to ship them. The pharma giant made the shocking revelation..
TMZ.com - Published

Pfizer Study Patient Says 2nd Vaccine Shot Hits Hard, 'Really Sick' but Not for Long

People who are getting the coronavirus vaccine don't know what's coming next -- that 2nd shot could hit like a ton of bricks, according to a guy who volunteered for Pfizer's study. Eric Gross joined us..
TMZ.com - Published

Pfizer Offering Placebo Patients Vaccine, Letting Them Jump the Line

Membership has its benefits -- people who participated in Pfizer's vaccine trial, but only got the placebo, now have the chance to get the real vaccine earlier ... TMZ has learned. Sources with direct..
TMZ.com - Published

Covid-19 vaccine pricing to help govts to ensure little to no out-of-pocket costs for people: Pfizer


IndiaTimes - Published

Vaccine deals: India, Oxford numbers see dip, but still on top; Pfizer gains most


IndiaTimes - Published

Pfizer Begins Shipping COVID Vaccines by FedEx and UPS

These images could foretell the end of the pandemic -- trucks have never looked so awesome!!! FedEx and UPS trucks rolled out of Pfizer's Kalamazoo, Michigan parking lot, carrying massive amounts of..
TMZ.com - Published

India readies for 60 crore COVID vaccine jabs; to use standard cold storage

Indian regulators are considering 3 vaccines for emergency use authorisation, including those from Pfizer Inc, AstraZeneca and Bharat Biotech.
DNA - Published

Pfizer Applies for Trademark for New Catchphrase in Marketing COVID Vaccine

Pfizer is in inevitable competition with the other drug companies that are developing COVID vaccines, and it's apparently trying to get a jump on its competitors with a new catchphrase. The..
TMZ.com - Published

Covid-19 vaccine to have differential pricing: Pfizer

"We are having a tier pricing. It is one price for the developed world based on their GDP, another price, lower for the middle-income countries and in the low-income countries, like countries in Africa..
IndiaTimes - Published

3 Covid-19 vaccine candidates under active consideration of drug regulator: Health ministry

Three Covid-19 vaccines candidates, developed by Bharat Biotech, Serum Institute of India and Pfizer, are under active consideration of India's drug regulator and there is hope that early licensure is..
IndiaTimes - Published

Covid-19: Day after Serum Institute of India, Bharat Bio seeks emergency nod for vaccine

Hyderabad-based Bharat Biotech filed an application seeking emergency use authorisation for Covaxin on Monday, becoming the third company to seek such regulatory approval in India after Pfizer and..
IndiaTimes - Published

Bharat Biotech seeks emergency use authorisation for indigenously developed Covid-19 vaccine Covaxin

After Pfizer and Serum Institute, Hyderabad-based pharmaceutical firm Bharat Biotech on Monday applied to the central drug regulator seeking emergency use authorisation for its Covid-19 vaccine..
IndiaTimes - Published

India speeding up review of Pfizer, Astra Covid-19 vaccines: Govt official

India is accelerating its review of coronavirus vaccines developed by Pfizer Inc and AstraZeneca for emergency use, a senior government official said on Monday, as the world's second-most affected..
IndiaTimes - Published

Pfizer becomes first pharma company in India to seek emergency use nod for its Covid-19 vaccine

Pfizer India has become the first pharmaceutical firm to approach the Drugs Controller General of India (DCGI) seeking an emergency use authorisation for its Covid-19 vaccine in the country. It is to..
IndiaTimes - Published

COVID-19: Pfizer seeks emergency use authorisation for its vaccine in India

In its application to DCGI, the company has requested approval for the import and distribution of vaccines in India.
DNA - Published

Pfizer seeks emergency use nod in India


IndiaTimes - Published

In talks with India on opportunity to roll out vaccine: Pfizer


IndiaTimes - Published

Sputnik’s ‘efficacy at 95%’, to be cheaper than US vaccines

Russia’s Sputnik V Covid-19 vaccine, that reported an efficacy of over 95%, will be twice as cheap as those by Pfizer and Moderna with similar positive results. Sputnik V, developed by Gamaleya..
IndiaTimes - Published

After Pfizer and Moderna, Oxford-AstraZeneca claims 90% efficacy of COVID-19 vaccine

According to the Oxford University release, no volunteer complained of any medical issue during the trial of the vaccine.
DNA - Published

Storage of Pfizer's Covid vaccine challenge for most nations; India examining possibilities: Govt

The cold-chain requirement for the anti-coronavirus vaccine candidate developed by Pfizer at a temperature of minus 70 degrees Celsius poses a big challenge, but the govt is working out a strategy for..
IndiaTimes - Published

India pins hopes on locally-tested Covid-19 vaccines given Pfizer constraints


IndiaTimes - Published

Moderna Says its COVID-19 Vaccine is 94.5% Effective

COVID-19 is about to get tag-teamed -- a second vaccine is on the way, and Moderna says this one has an even higher success rate than the first. On the heels of Pfizer's announcement it has a..
TMZ.com - Published

Pfizer vaccine results leave questions about safety, longevity


IndiaTimes - Published

Keeping Pfizer's Covid-19 vaccine at low temperatures will be challenging for India, others: AIIMS Director

Dr Randeep Guleria, Director, All India Institute of Medical Sciences Delhi (AIIMS), Delhi on Wednesday said the results of Pfizer's Covid-19 vaccine phase III trials are very encouraging but..
IndiaTimes - Published

Decision on Pfizer's Covid-19 vaccine will be based on regulatory approval: Centre


IndiaTimes - Published

Coronavirus vaccine: Centre in talks with Pfizer to make vaccine available for use in India

On Monday, Pfizer Inc and BioNTech SE announced more than 90% efficacy of their potential vaccine for the coronavirus infection.
DNA - Published

India in talks with all Covid vaccine manufacturers, domestic and foreign: Health ministry

A day after Pfizer Inc and BioNTech SE announced more than 90 per cent efficacy of their potential vaccine for the coronavirus, the health ministry on Tuesday said the National Expert Group on Vaccine..
IndiaTimes - Published

Vaccine Expert Peter Hotez Says Pfizer Vaccine Creates New Challenges

Buzzkill alert -- Dr. Peter Hotez is serving up a test tube full of very cautious optimism about Pfizer's huge coronavirus vaccine announcement. The renowned vaccine expert joined "TMZ Live" Monday to..
TMZ.com - Published

Pfizer Develops COVID Vaccine That's More than 90 Percent Effective

At last!!! It looks like a COVID vaccine is on the horizon that will change the world. Pfizer just released incredible data -- preliminary though it is -- showing they've developed a vaccine that is..
TMZ.com - Published

Congress seeks CBI probe into Kerala Covid-19 data deal

Even as Kerala CM Pinarayi Vijayan continues to maintain that all was fair in the transfer of coronavirus data to US-based Sprinklr, a Congress leader on Monday, demanded a CBI probe into it after..
IndiaTimes - Published

Pfizer identified some antiviral compounds with potential as coronavirus treatments

Drugmaker Pfizer Inc said on Monday that it identified certain antiviral compounds it had in development that have the potential to inhibit coronaviruses and is engaging with a third party to screen..
Reuters - Published